EGM
PASG icon

Engineers Gate Manager’s Passage Bio PASG Stock Holding History

Engineers Gate Manager’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,739
Closed -$24.3K – 2491
2024
Q3 		$24.3K Buy
+1,739
New +$27.7K ﹤0.01% 2016
2022
Q3 		– Sell
-540
Closed -$25K – 1967
2022
Q2 		$25K Buy
+540
New +$25.2K ﹤0.01% 1815

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Engineers Gate Manager's PASG Position: Q4 2024 in Review

Engineers Gate Manager sold out of Passage Bio (PASG) in Q4 2024, closing a stake of 1,739 shares — an estimated $24.3K sold.

Engineers Gate Manager first reported a position in PASG in Q2 2022 and held it in 2 quarters. The position peaked at $25K in Q2 2022. 44 funds tracked by Wall St. Rank hold PASG as of Q4 2024.

  • Engineers Gate Manager reported no remaining Passage Bio position as of Q4 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 1,739 Passage Bio shares in Q4 2024, an estimated $24.3K.
  • Engineers Gate Manager first reported a position in Passage Bio in Q2 2022 and held it in 2 quarters.
  • Engineers Gate Manager's Passage Bio position peaked at $25K in Q2 2022.
  • 44 funds tracked by Wall St. Rank held Passage Bio as of Q4 2024.

Based on Engineers Gate Manager's 13F filing for Q4 2024, filed 14 Feb 2025.